CD276 and neoplasm: The differences in cancer types or subtypes, the complexity of tumor heterogeneity, variations in sample sizes, variations in clinical stages, the timing of B7-H3 measurement during the course of the disease (and treatment), and the diverse methodologies employed in different research studies all contribute to the intricate puzzle of B7-H3’s role in cancer.